Complete Response to Trastuzumab-Based Chemotherapy in a Patient with Human Epidermal Growth Factor Receptor-2-Positive Metastatic Salivary Duct Carcinoma ex Pleomorphic Adenoma

Complete Response to Trastuzumab-Based Chemotherapy in a Patient with Human Epidermal Growth Factor Receptor-2-Positive Metastatic Salivary Duct Carcinoma ex Pleomorphic Adenoma

Introduction: Carcinoma ex pleomorphic adenoma (CXPA) of the salivary glands has often a salivary duct carcinoma (SDC) component, which resembles ductal carcinoma of the breast and frequently overexpresses human epidermal growth factor receptor-2 (HER2). We report a case of metastatic CXPA with SDC...

Full description

Bibliographic Details
Main Authors: Shigenori Kadowaki, Yasushi Yatabe, Hitoshi Hirakawa, Azusa Komori, Chihiro Kondoh, Yasuhisa Hasegawa, Kei Muro
Format: Article
Language:English
Published: Karger Publishers 2013-09-01
Series:Case Reports in Oncology
Subjects:
Trastuzumab
Carcinoma ex pleomorphic adenoma
Salivary duct carcinoma
Epidermal growth factor receptor-2
Complete response
Online Access:http://www.karger.com/Article/FullText/355219

Internet

http://www.karger.com/Article/FullText/355219

Similar Items